0001169245-21-000010.txt : 20210209 0001169245-21-000010.hdr.sgml : 20210209 20210209164803 ACCESSION NUMBER: 0001169245-21-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210205 FILED AS OF DATE: 20210209 DATE AS OF CHANGE: 20210209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sharp John P CENTRAL INDEX KEY: 0001342894 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 21607213 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD, STE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 4 1 wf-form4_161290725230899.xml FORM 4 X0306 4 2021-02-05 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001342894 Sharp John P C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355 0 1 0 0 Chief Financial Officer Employee Stock Option (right to buy) 4.31 2021-02-05 4 A 0 76500 0 A 2031-02-05 Common Stock 76500.0 76500 D The shares subject to the option shall vest in equal monthly installments over 48 months from February 5, 2021, subject to the reporting person's continued service through each such date. /s/ John P. Sharp 2021-02-09